Pretreatment Endorectal Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging Features of Prostate Cancer as Predictors of Response to External Beam Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 665-671

  Joseph, Tim ^a   McKenna, David A ^a   Westphalen, Antonio C ^a   Coakley, Fergus V ^a   Zhao, Shoujun ^a   Lu, Ying ^a   Hsu, I Chow ^b   Roach III, Mack ^b   Kurhanewicz, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer prostate; Magnetic resonance imaging; Outcome analysis; Radiotherapy; Spectroscopy prostate

Indexed keywords

ATOMS; BIOCHEMISTRY; DECISION MAKING; FAULT TOLERANT COMPUTER SYSTEMS; MAGNETIC MATERIALS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; METABOLISM; MULTIVARIANT ANALYSIS; NATURAL LANGUAGE PROCESSING SYSTEMS; QUALITY ASSURANCE; RADIOTHERAPY; SPIN POLARIZATION; TUMORS;

BIOCHEMICAL FAILURES; CANCER-PROSTATE; CONFIDENCE INTERVALS; COX ANALYSIS; EXTERNAL BEAM RADIOTHERAPIES; HAZARD RATIOS; INDEPENDENT PREDICTORS; KAPLAN-MEIER; MAGNETIC RESONANCE SPECTROSCOPIC IMAGING; MULTI-VARIATE ANALYSIS; OUTCOME ANALYSIS; PRE TREATMENTS; PROSTATE CANCERS; SEMINAL VESICLES; SPECTROSCOPY-PROSTATE; TUMOR SIZES; UNIVARIATE;

RESONANCE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METABOLISM; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RETROSPECTIVE STUDY; SEMINAL VESICLE; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR VOLUME;

AGED; ANALYSIS OF VARIANCE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 59649108542     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.056     Document Type: Article

References (34)

1. Obek C., Louis P., Civantos F., et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol 161 (1999) 494-498
2. Mettlin C.J., Black B., Lee F., et al. Workgroup 2. Screening and detection: Reference range/clinical issues of PSA. Cancer 71 (1993) 2679-2680
3. Salomon L., Colombel M., Patard J.J., et al. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol 35 (1999) 289-293
4. Smith J.A., Scardino P.T., Resnick M.I., et al. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: Results of a prospective multi-institutional trial. J Urol 157 (1997) 902-906
5. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 277 (1997) 1445-1451
6. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
7. Huch Boni R.A., Boner J.A., Debatin J.F., et al. Optimization of prostate carcinoma staging: Comparison of imaging and clinical methods. Clin Radiol 50 (1995) 593-600
8. Yu K.K., Hricak H., Alagappan R., et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: Multivariate feature analysis. Radiology 202 (1997) 697-702
9. 3) spatial resolution. Radiology 198 (1996) 795-805
10. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
11. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 (2002) 91-97
12. Coakley F.V., Qayyum A., and Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 170 (2003) S69-S75
13. D'Amico A.V., Whittington R., Malkowicz B., et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164 (2000) 759-763
14. Cooperberg M.R., Grossfeld G.D., Lubeck D.P., et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst 95 (2003) 981-989
15. McKenna D.A., Coakley F.V., Westphalen A.C., et al. Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy-initial experience. Radiology 247 (2008) 141-146
16. Star-Lack J., Vigneron D.B., Pauly J., et al. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging 7 (1997) 745-757
17. Schricker A.A., Pauly J.M., Kurhanewicz J., et al. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 46 (2001) 1079-1087
18. Tran T.-K.C., Vigneron D.B., Sailasuta N., et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 43 (2000) 23-33
19. Cabrera A.R., Coakley F.V., Westphalen A.C., et al. Is inapparent tumor at baseline endorectal MR imaging and MR spectroscopic imaging a positive prognostic finding in prostate cancer patients on active surveillance?. Radiology 247 (2008) 444-450
20. Jung J.A., Coakley F.V., Vigneron D.B., et al. Prostate depiction at endorectal MR spectroscopic imaging: Investigation of a standardized evaluation system. Radiology 233 (2004) 701-708
21. American Joint Committee on Cancer. Prostate. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC cancer staging manual. 6th ed. (2002), Springer, New York 309-316
22. Sadek A.G., Mitchell D.G., Siegelman E.S., et al. Early hepatocellular carcinoma that develops within macroregenerative nodules: Growth rate depicted at serial MR imaging. Radiology 195 (1995) 753-756
23. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized with cancer: Recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
24. Stromberg J., Martinez A., Benson R., et al. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treatment with up-front low dose rate iridium-192 prostate implantation and external beam irradiation. Int J Radiat Oncol Biol Phys 28 (1994) 67-75
25. Pickles T., and Pollack A. The case for dose escalation versus adjuvant androgen deprivation therapy for intermediate risk prostate cancer. Can J Urol 13 Suppl. 2 (2006) 68-71
26. Epstein J.I., Carmichael M., and Walsh P.C. Adenocarcinoma of the prostate invading the seminal vesicle: Definition and relation of tumor volume, grade, and margins of resection to disease prognosis. J Urol 149 (1993) 1040-1045
27. Clarke D.H., Banks S.J., Wiederhorn A.R., et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants. Int J Radiat Oncol Biol Phys 52 (2002) 903-910
28. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol 14 (1995) 1770-1777
29. D'Amico A.V., Whittington R., Malkowicz S.B., et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. J Urol 154 (1995) 131-138
30. Nguyen P.L., Whittington R., Koo S., et al. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 400-405
31. Sala E., Akin O., Moskowitz C.S., et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: Diagnostic accuracy and multivariate feature analysis. Radiology 238 (2006) 929-937
32. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: Correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
33. Yossepowitch O., Sircar K., Scardino P.T., et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 168 (2002) 2011-2015
34. Noguchi M., Stamey T.A., McNeal J.E., et al. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol 164 (2000) 1596-1600